1. |
刘梦奇, 吉顺荣, 徐晓武, 等. 2019 年胰腺癌研究及诊疗新进展. 中国癌症杂志, 2020, 30(1): 1-10.
|
2. |
王琛, 樊勇, 夏博伟. 微创时代下胰腺癌诊疗进展. 中华腔镜外科杂志(电子版), 2019, 12(5): 311-316.
|
3. |
Furuse J, Shibahara J, Sugiyama M. Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer. J Hepatobiliary Pancreat Sci, 2018, 25(5): 261-268.
|
4. |
Bacalbasa N, Balescu I, Vilcu M, <italic>et al</italic>. Pancreatoduodenectomy after neoadjuvant chemotherapy for locally advanced pancreatic cancer in the presence of an aberrant right hepatic artery. In Vivo, 2020, 34(1): 401-406.
|
5. |
Tsujimoto A, Sudo K, Nakamura K, <italic>et al</italic>. Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer. Sci Rep, 2019, 9(1): 16187.
|
6. |
孟庆榆, 刘淑杰, 代春梅, 等. MicroRNA-18a 对乳腺癌细胞 MCF-7/PTX 紫杉醇耐药性的影响. 武汉大学学报(医学版), 2020, 41(2): 225-230.
|
7. |
Streleckiene G, Inciuraite R, Juzenas S, <italic>et al</italic>. miR-20b and miR-451a are involved in gastric carcinogenesis through the PI3K/AKT/mTOR signaling pathway: Data from gastric cancer patients, cell lines and Ins-Gas mouse model. Int J Mol Sci, 2020, 21(3): pii: E877.
|
8. |
Xu K, Han B, Bai Y, <italic>et al</italic>. MiR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer. Cell Death Dis, 2019, 10(3): 152.
|
9. |
Wei GY, Hu M, Zhao L, <italic>et al</italic>. MiR-451a suppresses cell proliferation, metastasis and EMT <italic>via</italic> targeting YWHAZ in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci, 2019, 23(12): 5158-5167.
|
10. |
Nothnick WB, Swan K, Flyckt R, <italic>et al</italic>. Human endometriotic lesion expression of the miR-144-3p/miR-451a cluster, its correlation with markers of cell survival and origin of lesion content. Sci Rep, 2019, 9(1): 8823.
|
11. |
叶辰, 原春辉. 胰腺癌免疫微环境及免疫治疗的前景与展望. 中华外科杂志, 2019, 57(1): 10-15.
|
12. |
戴红梅, 洪夏飞, 庞海玉, 等. 主动脉旁淋巴结转移对胰腺癌可切除性影响的研究进展. 中华外科杂志, 2019, 57(1): 68-71.
|
13. |
Passardi A, Scarpi E, Neri E, <italic>et al</italic>. Chemoradiotherapy (gemox plus helical tomotherapy) for unresectable locally advanced pancreatic cancer: A phase Ⅱ Study. Cancers, 2019, 11(5): 663.
|
14. |
Caruso R, Quijano Y, Ferri V, <italic>et al</italic>. Venous resection for locally advanced pancreatic cancer: time trend and outcome analysis of 65 consecutive resections at a high-volume center. Surg Technol Int, 2019, 35: 92-99.
|
15. |
欧政林, 李宜雄, 纪连栋, 等. 胰腺癌新辅助治疗的共识及争议. 中华外科杂志, 2020, 58(2): 99-104.
|
16. |
Grasso C, Jansen G, Giovannetti E. Drug resistance in pancreatic cancer: Impact of altered energy metabolism. Crit Rev Oncol Hematol, 2017, 114: 139-152.
|
17. |
杜亚琼, 姜波健, 俞继卫. miRNA在胃癌发生发展中的作用. 中国普外基础与临床杂志, 2016, 23(4): 499-502.
|
18. |
Li Y, Wang J, Dai X, <italic>et al</italic>. miR-451 regulates FoxO3 nuclear accumulation through Ywhaz in human colorectal cancer. Am J Transl Res, 2015, 7(12): 2775-2785.
|
19. |
Su Z, Zhao J, Rong Z, <italic>et al</italic>. MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer. Int J Clin Exp Pathol, 2015, 8(8): 9154-9160.
|
20. |
Zang WQ, Yang X, Wang T, <italic>et al</italic>. MiR-451 inhibits proliferation of esophageal carcinoma cell line EC9706 by targeting CDKN2D and MAP3K1. World J Gastroenterol, 2015, 21(19): 5867-5876.
|
21. |
Yin P, Peng R, Peng H, <italic>et al</italic>. MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells. Mol Biotechnol, 2015, 57(1): 1-11.
|
22. |
Gu X, Li JY, Guo J, <italic>et al</italic>. Influence of MiR-451 on drug resistances of paclitaxel-resistant breast cancer cell line. Med Sci Monit, 2015, 21: 3291-3297.
|
23. |
常振宇, 张亚楠, 刘婕, 等. miR-451a 促进胰腺癌细胞对吉西他滨的敏感性. 生物技术通讯, 2019, 30(3): 308-314.
|
24. |
O’Reilly C, Doroudian M, Mawhinney L, <italic>et al</italic>. Targeting MIF in cancer: therapeutic strategies, current developments, and future opportunities. Med Res Rev, 2016, 36(3): 440-460.
|
25. |
Tian Y, Nan Y, Han L, <italic>et al</italic>. MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma. Int J Oncol, 2012, 40(4): 1105-1112.
|
26. |
罗燕, 陈志涛, 徐崇明, 等. VSL#3 通过 PI3K/Akt 信号通路调节溃疡性结肠炎大鼠调节性T细胞表达. 华中科技大学学报(医学版), 2019, 48(4): 411-416.
|
27. |
Goto T, Fujiya M, Konishi H, <italic>et al</italic>. An elevated expression of serum exosomal microRNA-191, -21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker. BMC Cancer, 2018, 18(1): 116.
|